According to AMR’s prediction, “Biopsy Devices Market by products (needle biopsy equipment, biopsy forceps, localization wires and other products), equipment (breast examination, gastroenterological biopsy, prostate biopsy, liver biopsy, lung biopsy, kidney biopsy, gynecological biopsy and others) , Imaging Technology ( MRI-Guided Biopsy , Stereotaxy-Guided Biopsy, Ultrasound-Guided Biopsy, CT Scan and Others) and End User (Diagnostics and Imaging Companies, Hospitals and Others): Global Opportunity Study and Industry Market Forecast , 2019-2026.” As per the report, the global biopsy devices industry was estimated at $2.72 billion in 2018, and is expected to hit $4.31 billion by 2026, registering a CAGR of 5.9% during the study period.
♦ 𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐅𝐫𝐞𝐞 𝐏𝐃𝐅 𝐁𝐫𝐨𝐜𝐡𝐮𝐫𝐞:
Key Findings of the Study –
- Based on product, the needle biopsy equipment segment accounted for 37.48% of the global market share in 2018.
- Based on application, the breast biopsy segment has the highest market share in 2018 and is expected to continue during the forecast period.
- Based on imaging technology, the CT biopsy segment is showing rapid growth and is expected to grow at a CAGR of 6.6% from 2019 to 2026.
Based on application, breast segment accounted for more than one-fifth of the global biopsy device market in 2018 and is expected to dominate throughout the forecast period. This is due to the use of needle biopsy equipment in breast biopsy. The lung segment, on the other hand, is expected to grow at the fastest CAGR of 7.6% during the study period. This is due to the large increase in lung cancer worldwide.
On an end-user basis, the clinical sector gained the largest share in 2018, holding nearly two-fifths of the global biopsy device market. Easy access to biopsy tools and equipment in hospitals has fueled that growth. At the same time, the diagnostic and imaging segment will register the fastest CAGR of 6.6% through 2026. Low process costs are driving the growth.
♦ 𝐅𝐨𝐫 𝐏𝐮𝐫𝐜𝐡𝐚𝐬𝐞 𝐈𝐧𝐪𝐮𝐢𝐫𝐲 𝐨𝐟 𝐑𝐞𝐩𝐨𝐫𝐭:
North America accounted for the largest share of the Biopsy Devices market size and is expected to continue this trend due to availability of well-developed infrastructure, presence of several key players, increasing number of cancer patients and availability of qualified health professionals. On the other hand, Asia-Pacific is expected to register the fastest growth during the forecast period.
Key Market Players –
Major key players that operate in the industry are Argon Medical Devices, Inc., B. Braun Melsungen AG, Becton Dickinson and Company (C.R. Bard, Inc.), Boston Scientific Corporation, Cardinal Health, Inc., Cook Medical, Inc., Danaher Corporation (Leica Microsystem), Fujifilm Holdings Corp., Hologic, Inc., and Medtronic plc.
By Region –
North America (U.S., Canada, Mexico)
Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
LAMEA (Brazil, Saudi Arabia, South Africa, Rest of LAMEA)
Asia-Pacific (Japan, China, Australia, India, South Korea, Rest of Asia-Pacific)
♦ 𝐁𝐮𝐲 𝐍𝐨𝐰 𝐓𝐡𝐢𝐬 𝐄𝐱𝐜𝐥𝐮𝐬𝐢𝐯𝐞 𝐑𝐞𝐩𝐨𝐫𝐭:
Frequently Asked Questions?
Q1. What is the total market value of global Biopsy Devices Market?
Q2. Which market holds the maximum market share of the global Biopsy Devices Market?
Q3. What will be global Biopsy Devices Market growth in 2030?
Q4. What are the key trends in the global Biopsy Devices Market?
Q5. What are the key growth strategies of global Biopsy Devices Market players?
Q6. How the company profile has been selected?
About Us –
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
Pawan Kumar, the CEO of Allied Market Research, is leading the organization toward providing high-quality data and insights. We are in professional corporate relations with various research data tables and confirms utmost accuracy in our market forecasting. Each and every us companies and this helps us in digging out market data that helps us generate accurate y data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.
5933 NE Win Sivers Drive
#205, Portland, OR 97220
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060